Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Aim: To estimate the prevalence of Alzheimer’s disease (AD) and other dementias in the USA using a nationally representative sample. Methods: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. Results: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71–79 years to 37.4% of those aged 90 and older. Conclusions: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [316]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [343]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 3×
“S.[3] The four previous national estimates of AD prevalence estimates differed by greater than two-fold and ranged from 2.”
BackgroundMethodRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“Currently accepted diagnostic criteria for subtypes of dementia were used.[19-21, 27] DSM criteria for dementia require memory impairment, however some subtypes of dementia do not present with prominent memory problems.”
MethodAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“5 million.[5,26] The lowest estimate came from a meta-analysis of 18 US and European studies; the highest from the East Boston and Chicago community studies.”
BackgroundBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“[2-6], all employing extrapolations from a few U.”
Method
Research works printed but not linked: 6
- Evans DA, Scherr PA, Cook NR, Albert MS, Funkenstein HH, Smith LA, Hebert LE, Wetle TT, Branch LG, Chown M, Hennekens CH, Taylor JO. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–289. [PubMed] [Google Scholar]
- United States General Accounting Office . Alzheimer's Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- Willis RJ. Theory confronts data: how the HRS is shaped by the economics of aging and how the economics of aging will be shaped by the HRS. Labour Econ. 1999;6:119–145. [Google Scholar]
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington: American Psychiatric Association; 1987. [Google Scholar]
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122. doi: 10.1001/archneur.60.8.1119. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- 10.1001%2fjama.278.16.1349 · doi:10.1001/jama.278.16.1349 · Paper page
Cited by
Items 901–1,000 of 1,002
Ayalon, L. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31818cd3d3 · Cited by 21
More Education May Limit Disability and Extend Life For People With Cognitive Impairment
Laditka, S. B., & Laditka, J. N. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518648 · Cited by 22
Hypothesis Testing in Unsupervised Domain Adaptation with Applications in Alzheimer's Disease.
Zhou, H., Ravi, S. N., Ithapu, V. K., Johnson, S. C., Wahba, G., & Singh, V. (2016) · PubMed · Cited by 24
Association Between Oral Health and Cognitive Status: A Systematic Review
Wu, B., Fillenbaum, G. G., Plassman, B. L., & Guo, L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14572 · Cited by 20
Self-citationSex Differences in in vivo Alzheimer’s Disease Neuropathology in Late Middle-Aged Hispanics
Luchsinger, J. A., Palta, P., Rippon, B., Soto, L., Ceballos, F., Pardo, M., Laing, K. K., Igwe, K. C., Johnson, A. S., Tomljanovic, Z., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191183 · Cited by 21
“In the Aging, Demographics, and Memory Study (ADAMS) of individuals 71 years and older in the United States, 16% of females had dementia compared with 11% of males [25].”
Menopause, cognitive ageing and dementia: practice implications
Henderson, V. W. (2009) · Menopause international · doi:10.1258/mi.2009.009003 · Cited by 20
Mirabian, S., Mohammadian, F., Ganji, Z., Zare, H., & Khalesi, E. H. (2025) · The Neuroradiology Journal · doi:10.1177/19714009251313511 · Cited by 20
HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia
Venkat, P., Culmone, L., Chopp, M., Landschoot‐Ward, J., Wang, F., Zacharek, A., & Chen, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00258 · Cited by 19
“12:258. doi: 10.3389/fnagi.2020.00258 HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia Poornima Venkat1*, Lauren Culmone1, Michael Chopp1,2 Julie Landschoot-Ward1, Fengjie Wang1, Alex Zacharek1 and Jieli Chen1* 1Department of Neurology, Henry Ford Hospital, Detroit, MI, United States, 2Departm…”
BackgroundInfluentialThe Influence of Cognitive Impairment on Postoperative Outcomes
Blair, E. M., Levine, D. A., Hu, H. M., Langa, K. M., Kabeto, M. U., & Waljee, J. F. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004799 · Cited by 19
Self-citationThe updated prevalence and risk factors of dementia in old adults in China: A cross-sectional study
Gan, J., Zeng, Y., Huang, G., Wang, X., Lü, Y., Niu, J., Meng, X., Cai, P., Li, X., Li, Y., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241297155 · Cited by 20
Lee, Y., & Bronstein, L. R. (2010) · Journal of Ethnic & Cultural Diversity in Social Work · doi:10.1080/15313200903547756 · Cited by 19
“4 million people in the United States are affected by dementia ( Plassman et al, 2007 ) and almost 10 million Americans are providing unpaid care for a person with dementia ( Alzheimer's Association, 2009 ).”
BackgroundThe LIFE Cognition Study: design and baseline characteristics
Sink, K. M., Williamson, J. D., Espeland, M. A., Rushing, J., Castro, C. M., Church, T. R., Cohen, R., Gill, T. M., Henkin, L. F., Jennings, J., et al. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s65381 · Cited by 20
Kao, H., Liou, M., Chung, H., Liu, H.-S., Tsai, P.-H., Chiang, S., Chou, M., Peng, G., Huang, G.-S., Hsu, H., et al. (2015) · Medicine · doi:10.1097/md.0000000000001546 · Cited by 22
“4% in those aged 90 and older.(1,2) The clinical presentations of dementia are nonspecific and various aspects of cognition, such as memory, attention, language, and problem solving, could be affected.”
Backgroundda Rosa, M. I., Beck, W. O., Colonetti, T., Budni, J., Falchetti, A. C. B., Colonetti, L., Coral, A. S., & Meller, F. D. O. (2019) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12636 · Cited by 24
Cichosz, S. L., Jensen, M. H., & Hejlesen, O. K. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.11.005 · Cited by 21
Schneider, C., Bristol, A. A., Ford, A., Lin, S., Palmieri, J., Meier, M., & Brody, A. A. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.05.010 · Cited by 19
Prompt Outpatient Care For Older Adults Discharged From The Emergency Department Reduces Recidivism
Magidson, P. D., Huang, J., Levitan, E. B., Westfall, A. O., Sheehan, O. C., & Roth, D. L. (2020) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.8.47276 · Cited by 19
Liu, H., & Wu, L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.696015 · Cited by 20
“The prevalence of AD was conservatively estimated at 5% for people over 60 in 2007 (3), and the number of people diagnosed with AD worldwide may reach 100 million by 2050 (4).”
BackgroundTreatment for Lexical Retrieval in Primary Progressive Aphasia
Rising, K. (2014) · Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders · doi:10.1044/nnsld24.4.137 · Cited by 19
“Recent data from The Aging, Demographics, and Memory Study (Plassman et al., 2007) suggest that over 3 million people in the United States aged 71 and older have dementia from varying etiologies.”
Trojanowski, J. Q., Arnold, S. E., Karlawish, J. H., Naylor, M. D., Brunden, K. R., & Lee, V. M. ‐. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.08.005 · Cited by 20
Takahashi, P. Y., Caldwell, & Targonski (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s28143 · Cited by 19
“Introduction Vascular dementia (VaD) is a common condition that affected the lives of 594,000 people in the US in 2007.(1) This number will grow as the population ages and as individuals live longer lives with vascular disease.”
Risks and Benefits of Antipsychotic Drugs in Elderly Patients with Dementia
Howland, R. H. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20081101-05 · Cited by 21
Lowe, X. R., & Wyrobek, A. J. (2012) · Current Genomics · doi:10.2174/138920212802510448 · Cited by 20
“The prevalence of Alzheimer’s disease (AD) and other dementias will continue to increase with the rapid growth of our older population [2, 3].”
BackgroundThe Assessment of Decisional Capacity
Lim, T., & Marin, D. B. (2010) · Neurologic Clinics · doi:10.1016/j.ncl.2010.10.001 · Cited by 19
Reinventing Neuroaging Research in the Digital Age
Huentelman, M. J., Talboom, J. S., Lewis, C. R., Chen, Z., & Barnes, C. A. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.11.004 · Cited by 19
Rist, P. M., Marden, J. R., Capistrant, B. D., Wu, Q., & Glymour, M. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141866 · Cited by 18
“4 million Americans over the age of 71 are affected by mild cognitive impairment or dementia [36], there is no known cure and treatments have modest if any benefits.”
Pierce, M., Cahill, S. M., & O’Shea, E. (2013) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2012.3 · Cited by 18
“The risk of developing dementia increases exponentially with age (Plassman et al. 2007), and population ageing means that, unless a cure is found in the foreseeable future, increasing numbers of people around the world will develop dementia.”
BackgroundInfluentialSchaefer, K. R., Noonan, C., Mosley, M., Smith, J., Galbreath, D., Fenn, D., Robinson, R. F., & Manson, S. M. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.4945 · Cited by 18
Passler, J. S., Kennedy, R., Crowe, M. G., Clay, O. J., Howard, V. J., Cushman, M., Unverzagt, F. W., & Wadley, V. G. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz045 · Cited by 18
“(Plassman et al., 2007), there was also a 22.2% prevalence of cognitive impairment without dementia in that sample (Plassman et al., 2008) for a combined MCI/dementia prevalence of 36% in ADAMS.”
BackgroundInfluentialBeaudreau, S. A., Kaci Fairchild, J., Spira, A. P., Lazzeroni, L. C., & O'Hara, R. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3868 · Cited by 17
“In a previous investigation in the Aging, Demographics, and Memory Study (ADAMS), APOE e4 was independently associated with dementia status at the study baseline (Plassman et al., 2007) and predicted conversion to dementia at 16 to 18months in individuals with CIND (Plassman et al.”
BackgroundOral health in older adults with dementia living in different environments: a propensity analysis
Chen, X., Clark, J. J. J., & Naorungroj, S. (2013) · Special Care in Dentistry · doi:10.1111/scd.12006 · Cited by 18
PRND3′UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease
Flirski, M., Sieruta, M., Golańska, E., Kłoszewska, I., Liberski, P. P., & Sobów, T. (2012) · Prion · doi:10.4161/pri.6.1.18428 · Cited by 20
“Alzheimer disease (AD) is the most common cause of dementia, accounting for approximately 70% of cases in subjects over 70 years.(1) Cognitive impairment leading to functional decline, dementia defining symptom, is frequently accompanied by diverse behavioral changes and neuropsychiatric symptoms clustered together as…”
BackgroundLateral temporal hyper-activation as a novel biomarker of mild cognitive impairment
Faraco, C. C., Puente, A. N., Brown, C. L., Terry, D. P., & Miller, L. S. (2013) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.07.023 · Cited by 20
“9% of individuals over the age of 70 undergoing a dementing process, AD has been estimated to account for nearly 70% of cases (Plassman et al., 2007).”
BackgroundInfluentialFamily reports of medically impaired drivers in Missouri: Cognitive concerns and licensing outcomes
Meuser, T. M., Carr, D. B., Unger, E. A., & Úlfarsson, G. F. (2014) · Accident Analysis & Prevention · doi:10.1016/j.aap.2014.10.002 · Cited by 20
Park, J., & Lee, C. H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.248 · Cited by 18
“Vascular dementia, mainly caused by alteration of blood supply to the brain, is the second most common type of dementia (Plassman et al., 2007).”
BackgroundThe association between estradiol levels and cognitive function in postmenopausal women
Gholizadeh, S., Sadatmahalleh, S. J., & Ziaei, S. (2018) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.16.7.455 · Cited by 20
“(20, 21).”
Feis, R. A., Bouts, M. J. R. J., Dopper, E. G. P., Filippini, N., Heise, V., Trachtenberg, A. J., Swieten, J. C. V., van Buchem, M. A., van der Grond, J., Mackay, C. E., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1567-0 · Cited by 18
Chetia, P., Mazumder, M. K., Mahanta, S., De, B., & Choudhury, M. D. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109839 · Cited by 18
Preexisting Mild Cognitive Impairment, Dementia, and Receipt of Treatments for Acute Ischemic Stroke
Levine, D. A., Gałecki, A. T., Morgenstern, L. B., Zahuranec, D. B., Langa, K. M., Kabeto, M. U., Okullo, D., Nallamothu, B. K., Giordani, B., Reale, B. K., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.032258 · Cited by 18
Self-citationWalsh, C., Yang, Y. C., Oi, K., Aiello, A. E., Belsky, D. W., Harris, K. M., & Plassman, B. L. (2022) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbac038 · Cited by 19
Self-citationCognitive Function Assessment in Patients on Moderate- or High-Intensity Statin Therapy
Roy, S., Hyman, D., Ayyala, S., Bakhshi, A., Kim, S. H., Anoruo, N., Weinstock, J. L., Balogun, A., D’Souza, M., Filatova, N., et al. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4144 · Cited by 18
Epidemiology of Alzheimer’s Disease
Xu, W., Ferrari, C., & Wang, H. (2013) · InTech eBooks · doi:10.5772/54398 · Cited by 22
Sanchez, M. A., & Lourenço, R. A. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00966.x · Cited by 18
Education and Dementia Risk: Results From the Aging Demographics and Memory Study
Basu, R. (2012) · Research on Aging · doi:10.1177/0164027511434086 · Cited by 21
“Full details of the ADAMS sample design and selection methods are described in other studies (Langa et al., 2005; Plassman et al., 2007).”
MethodChanti‐Ketterl, M., Pathak, E. B., Andel, R., & Mortimer, J. A. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4078 · Cited by 18
“Based on 2002 estimates using a representative subsample of the US population-based Health and Retirement Study 70 years and older, about 14% had dementia (Plassman et al., 2007).”
MethodIncreasing Burden of Complex Multimorbidity Across Gradients of Cognitive Impairment
Koroukian, S. M., Schiltz, N. K., Warner, D. F., Stange, K. C., & Smyth, K. A. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517726388 · Cited by 19
Can Smartphones Enhance Telephone-Based Cognitive Assessment (TBCA)?
Kwan, R. Y. C., & Lai, C. K. Y. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10127110 · Cited by 18
Rashid, F., Khan, K. M., Saiprakash, S., Ahmed, G., Sultana, R., Parvez, F., Islam, Z., & Rahaman, M. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113776 · Cited by 19
“Women live longer than men, making them more likely to reach an age to develop AD/ADRD [22].”
How good are medical and death records for identifying dementia?
Schliep, K. C., Ju, S., Foster, N. L., Smith, K. R., Varner, M. W., Østbye, T., & Tschanz, J. T. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12526 · Cited by 17
Dinesh, D., Shao, Q., Palnati, M., McDannold, S. E., Zhang, Q., Monfared, A. A. T., Jasuja, G. K., Davila, H. W., Xia, W., Moo, L. R., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13071 · Cited by 18
Serum neurofilament light chain and cognition decline in US elderly: A cross‐sectional study
Liu, X., Chen, J., Meng, C., Zhou, L., & Liu, Y. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51929 · Cited by 18
Krishnan, A., Pathak, A., Nicholas, T. B., Lee, J., Waite, L. M., & Stanaway, F. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085592 · Cited by 18
Sex differences in Alzheimer's disease risk: are we looking at the wrong hormones?
Munro, C. A. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001549 · Cited by 17
Annual Period Prevalence and Risk Factors of Dementia Among Older Jordanian Hospitalized Patients
Kofahi, R. M., Aljezawi, M., Abdalrahim, A., Qadire, M. I. A., Obiedat, D., & Aqaileh, S. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s299353 · Cited by 18
Mezzaca, T. A., Dodds, L. V., Rundek, T., Hazzouri, A. Z. A., Caunca, M. R., Gomes‐Osman, J., Loewenstein, D., Schneiderman, N., & Elfassy, T. (2022) · Journal of Aging and Health · doi:10.1177/08982643221076690 · Cited by 17
“This corroborates the findings of other studies, which have found poor cognitive functioning to be a marker of dementia (Petersen, 2004; Plassman et al., 2007).”
ResultNew Approaches to the Pathology and Genetics of Neurodegeneration
Feany, M. Β. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091077 · Cited by 19
“Alzheimer disease is the most prevalent neurodegenerative disorder and affects about 10% of people over the age of 70.(1) Parkinson disease is next in frequency, with a prevalence of approximately 2% of individuals over the age of 70.”
BackgroundDying in Hospital with Dementia and Pneumonia: A Nationwide Study Using Death Certificate Data
Houttekier, D., Reyniers, T., Deliëns, L., Noortgate, N. J. V. D., & Cohen, J. (2013) · Gerontology · doi:10.1159/000354378 · Cited by 17
A Music Intervention's Effect on Falls in a Dementia Unit
Gill, L. M., & Englert, N. C. (2013) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2013.05.005 · Cited by 17
Common Dietary Supplements for Cognitive Health
Gestuvo, M., & Hung, W. (2012) · Aging Health · doi:10.2217/ahe.11.92 · Cited by 21
Habitual Coffee Consumption Enhances Attention and Vigilance in Hemodialysis Patients
Nikić, P. M., Andrić, B., Stojimirovic, B. B., Stankovic, J. T., & Bukumirić, Z. (2014) · BioMed Research International · doi:10.1155/2014/707460 · Cited by 17
Seo, H., Jeon, J., Chung, W., & Kim, N. (2016) · International Journal of Dental Hygiene · doi:10.1111/idh.12194 · Cited by 17
Rose, S. M. S., Xie, D., Streim, J. E., Pan, Q., Kwong, P. L., & Stineman, M. G. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1774-y · Cited by 17
“44) for the age 71 and above group [31], but still reasonably close considering the different sampling frames, years (2002 vs.”
BackgroundResultDifferentiating among Depression, Delirium, and Dementia in Elderly Patients
Gagliardi, J. P. (2008) · The AMA Journal of Ethic · doi:10.1001/virtualmentor.2008.10.6.cprl1-0806 · Cited by 24
The importance of bilingualism for the aging brain: Current evidence and future research directions
Sullivan, M. D., & Bialystok, E. (2017) · Studies in bilingualism · doi:10.1075/sibil.53.01sul · Cited by 16
Weiss, J. (2021) · SSM - Population Health · doi:10.1016/j.ssmph.2021.100979 · Cited by 18
“Studies indicate that the prevalence of dementia may be twice as high among non-Hispanic black (Gurland et al., 1999; Plassman et al., 2007; Potter et al., 2009) and one and one-half times higher among Hispanic (Gurland et al.”
BackgroundGenetics of cognitive dysfunction in Parkinson's disease
Wise, A. H., & Alcalay, R. N. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.015 · Cited by 17
Park, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19169950 · Cited by 18
“Given that over 10% of patients with MCI experience Alzheimer’s disease (AD) within three years, it is important to discriminate older adults with MCI early before they show obvious clinical signs of AD to reduce enormous social costs [2].”
BackgroundAlzheimer’s Disease: Current Trends in Wales
Opeyemi, J. A. G. (2014) · Oman Medical Journal · doi:10.5001/omj.2014.73 · Cited by 16
“Type of AD, n (%) Early onset AD Late onset AD Unspecified AD Other types 999 (7) 4435 (31) 7619 (52) 1481 (10) 354 (15) 544 (22) 1323 (55) 207 (9) 406 (4) 3873 (33) 6188 (53) 1242 (11)”
The Level of Cognitive Impairment and Likelihood of Frequent Hospital Admissions
Amini, R., Chee, K. H., Swan, J. H., Mendieta, M., & Williams, T. (2017) · Journal of Aging and Health · doi:10.1177/0898264317747078 · Cited by 17
Roberts, J. R., & Maxfield, M. (2018) · Journal of Religion and Health · doi:10.1007/s10943-018-0635-x · Cited by 18
“Although some rare cases of AD occur relatively early in life (affecting approximately 5% of those diagnosed with AD; Mendez 2012), advanced age is the primary risk factor (Alzheimer’s Association 2015; Plassman et al. 2007).”
BackgroundBrent, R. J. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1904079 · Cited by 19
“9% of the population aged 71 and over [20].”
BackgroundThe Prevalence of Mild Cognitive Impairment in a Convenience Sample of 202 Gulf War Veterans
Chao, L. L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197158 · Cited by 16
Sanchez-Flack, J., Tussing-Humphreys, L. M., Lamar, M., Fantuzzi, G., Schiffer, L. A., Blumstein, L. B., McLeod, A., Dakers, R., Strahan, D. C., Restrepo, L., et al. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101302 · Cited by 19
Jang, J. B., Hicken, M. T., Mullins, M. A., Esposito, M. H., Sol, K., Manly, J. J., Judd, S. E., Wadley, V. G., & Clarke, P. J. (2021) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbab107 · Cited by 17
Fan, Y., Shen, M., Huo, Y., Gao, X., Li, C., Zheng, R., & Zhang, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.698035 · Cited by 19
“…(Kivipelto et al., 2001; Casserly and Topol, 2004; Vuorinen et al., 2015), and APOEε4 allele gene (Schuur et al., 2011; Sudre et al., 2017; Rojas et al., 2018), have been found in both AD and VaD, which shared common pathophysiological mechanisms including oxidative stress, mitochondrial…”
BackgroundChen, L.-G., Wang, C., Lee, Y.-S., Sie, Y.-Y., Chang, C., & Hou, W. (2022) · Biomedicines · doi:10.3390/biomedicines10020273 · Cited by 17
“The Alzheimer’s disease (AD) accounted for on average 70% all dementia populations [2]: those who are characterized by memory lapses to shortterm memory impairments, dysfunctions in expressing thoughts and performing routine tasks, and spatial awareness dysfunctions, and finally the loss of ability to participate the”
BackgroundQiao, Z., Wang, G., Zhao, X. B., Wang, K., Fan, D., Chen, Q., & Ai, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.841942 · Cited by 18
“Alzheimer’s disease (AD) is a primary neurodegenerative disease and one of the most common clinical types of dementia, accounting for up to 70% of cases (Plassman et al., 2007).”
BackgroundBritt, K. C., Richards, K. C., Acton, G. J., Hamilton, J. B., & Radhakrishnan, K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054300 · Cited by 18
“An HRS sub-study including participants aged 70 years and older, ADAMS, was sponsored by the National Institute of Aging (grant number NIA U01AG009740) and is a high-quality sample of 1770 individuals stratified from a random subsample across five cognitive strata [19,20].”
MethodChronic kidney disease and cognitive impairment among the very old in China
Wang, H., Fang, C., Cai, L., Dong, B., & Deng, J. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0433-1 · Cited by 20
“Cognitive impairment, like CKD, is also a common condition in the elderly that have growing public health significance [1].”
Chen, X., & Clark, J. J. J. (2012) · Special Care in Dentistry · doi:10.1111/scd.12005 · Cited by 16
Cognitive function and exercise training for chronic renal disease patients: A literature review
Καλτσάτου, Α., Grigoriou, S. S., Karatzaferi, C., Giannaki, C. D., Stefanidis, I., & Sakkas, G. K. (2015) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2015.04.006 · Cited by 21
“Consequently, both conditions needed greater healthcare as they are associated with poorer quality of life (QoL) and increased mortality (Levey et al., 2003; Plassman et al., 2007).”
BackgroundHuang, Y.-Y., Kung, P., Chiu, L.-T., & Tsai, W. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.10.019 · Cited by 16
Huang, Z., & Maurer, J. (2017) · Assessment · doi:10.1177/1073191117741188 · Cited by 19
“Memory loss is a major public health challenge in aging populations (Koivisto et al., 1995; Plassman et al., 2007; Prince et al., 2013), as poor memory has profound consequences for older people’s everyday lives.”
BackgroundCoe, Á., Martin, M., & Stapleton, T. (2019) · Occupational Therapy In Health Care · doi:10.1080/07380577.2018.1543911 · Cited by 17
Bailly, L., David, R., Chevrier, R., Grebet, J., Moncada, M., Fuch, A., Sciortino, V., Robert, P. H., & Pradier, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216221 · Cited by 16
Expression and purification of amyloid β-protein, tau, and α-synuclein in Escherichia coli: a review
Jia, L., Zhao, W., Wei, W., Guo, X. L., Wang, W., Wang, Y., Sang, J., Lu, F., & Liu, F. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1742646 · Cited by 18
Molinari, V., Edelstein, B. A., Gibson, R., Lind, L. M., Norris, M. P., Carney, K., Bush, S. S., Heck, A. L., Moye, J. A., Gordon, B. H., et al. (2020) · Professional Psychology Research and Practice · doi:10.1037/pro0000298 · Cited by 18
“The prevalence of dementia increases with age, with an estimated 5% prevalence of dementia among individuals between the ages of 71 and 79, and over 37% for those 90 and over (Plassman et al., 2007).”
BackgroundSrisaikaew, P., Wongpakaran, N., Anderson, N. D., Chen, J. J., Kothan, S., Varnado, P., Unsrisong, K., & Mahakkanukrauh, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.594002 · Cited by 17
“VaD is the second most common cause of dementia after AD, causing 20–30% of global dementia cases (Alzheimer’s Disease International, 2014), 15–20% in North America and Europe (Plassman et al., 2007; Rizzi et al., 2014), and∼30% in Asia (Jhoo et al.”
BackgroundMeyer, C., Young, J. A., & Lind, C. (2016) · Seminars in Hearing · doi:10.1055/s-0036-1584410 · Cited by 18
“In this same age bracket, almost 14% of adults have dementia.(3) Furthermore, a growing body of research identifies an association between HI and dementia.”
BackgroundReiman, E. M., & Langbaum, J. B. S. (2009) · Imaging the Aging Brain · doi:10.1093/acprof:oso/9780195328875.003.0020 · Cited by 16
Abuse of older people with dementia: a review
Downes, C., Fealy, G., Phelan, A. A., Donnelly, N.-A., & Lafferty, A. (2013) · Lenus, The Irish Health Repository (Dr Steevens Hospital Library) · Cited by 24
Extracellular Tau Oligomers Damage the Axon Initial Segment
Best, M. N., Lim, Y., Ferenc, N. N., Kim, N., Min, L. Y., Wang, D. B., Sharifi, K., Wasserman, A. E., McTavish, S. A., Siller, K. H., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221284 · Cited by 15
Mandal, K., Morrison, A. M., & Bag, S. (2024) · Tourism Management · doi:10.1016/j.tourman.2024.105100 · Cited by 16
Jefferson, A. L., Lambe, S. A., Romano, R. R., Liu, D., Islam, F., & Kowall, N. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130287 · Cited by 15
“In light of the expected doubling of AD prevalence over the next two decades [2], engaging African American elders in research to advance prevention and treatment efforts is a critical component in minimizing the public health implications of AD and its impact on the African American community.”
Assessment of older drivers in New Zealand: The current system, research and recommendations
Hoggarth, P. A., Innes, C., Dalrymple‐Alford, J. C., Croucher, M., Severinsen, J., Gray, J. P., Oxley, J., Brook, B., ABERNETHY, P. J., & Jones, R. D. (2011) · Australian Journal on Ageing · doi:10.1111/j.1741-6612.2010.00478.x · Cited by 15
Demystifying eldercare: Managing and innovating from a public-entity's perspective
Schultz, J., André, B., & Sjøvold, E. (2014) · International Journal of Healthcare Management · doi:10.1179/2047971914y.0000000097 · Cited by 15
“9% those aged 85+); (75) (5% dementia those aged 71-79”
Florbetapir F 18 for brain imaging of beta-amyloid plaques
Romano, M., & Buratti, E. (2013) · Drugs of today · doi:10.1358/dot.2013.49.3.1937428 · Cited by 19
Mahendra, N., Scullion, A., & Hamerschlag, C. (2011) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0b013e31821e5945 · Cited by 15
Amoyal, N. R., & Fallon, E. A. (2012) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0b013e31825fc8d3 · Cited by 16
Hausman, H. K., Alexander, G. E., Cohen, R., Marsiske, M., DeKosky, S. T., Hishaw, G. A., O'Shea, A., Kraft, J. N., Dai, Y., Wu, S., et al. (2023) · Brain Stimulation · doi:10.1016/j.brs.2023.05.021 · Cited by 13
“Non-Hispanic Black/African American and Hispanic individuals have a higher prevalence of dementia than White individuals, which can be explained by disparities in health and lived experiences due to structural racism [73-80].”
Metadata
- Authors
- Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., Steffens, D. C., Willis, R. J., & Wallace, R. B.
- Affiliations
- Duke University (US)
- University of Michigan (US)
- Duke Medical Center (US)
- RAND Corporation (US)
- University of Iowa (US)
- ORCID
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 29
- Issue
- 1-2
- Pages
- 125-132
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- PMC
- PMC2705925
- OpenAlex
- W2133488570
- Cited by
- 1,932
- References
- 44
- Citations by year
- 2026: 36 · 2025: 77 · 2024: 68 · 2023: 76 · 2022: 109 · 2021: 144 · 2020: 152 · 2019: 108 · 2018: 107 · 2017: 111 · 2016: 122 · 2015: 123 · 2014: 153 · 2013: 126 · 2012: 121
- FWCI
- 38.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08AG019180, U01 AG 09740, U01AG009740)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia prevalence, Alzheimer's disease, vascular dementia, older adults, cognitive impairment, age differences, sex differences, population aging, health planning
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Health Surveys, Humans, Male, United States, Cohort Studies, Geriatric Assessment, Prevalence, Logistic Models, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.